CellWell record HH-144804
eGFR- and Potassium-Guided Stewardship of SGLT2 Inhibitors and Finerenone in Albuminuric Chronic Kidney Disease Associated with Type 2 Diabetes
Chen Su; Xumin Li; Shuang Wang; Dan Liu
2026
In plain language
This narrative review proposes an eGFR- and potassium-guided framework for sequencing SGLT2 inhibitors and finerenone in diabetic kidney disease, noting a trial found their combination cut albuminuria more than either drug alone.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-144804
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.